Laryngeal Cancer Overview
Laryngeal Cancer Overview
Laryngeal cancer begins in the larynx — the voice box. It is the structure at the front of the neck that makes the voice and closes off the airway when you swallow, and it is small enough to examine directly with a telescope. Almost all of these cancers are squamous cell carcinomas, and almost all of them are linked to tobacco, with alcohol acting alongside it. What makes cancer here different from most head and neck cancers is a single anatomical fact: the larynx is built in three regions, and where a tumour starts decides how early it is found and where it goes first.
-
Three regions
glottis, supraglottis and subglottis — the region sets how early it is found
-
Hoarseness
a voice change lasting more than three weeks is the signal that brings most of these to light
-
Two aims at once
remove the cancer and keep a voice and a safe swallow, wherever the tumour allows
-
48 hrs
from complete records to a personalized MDT plan
What laryngeal cancer is
The larynx sits in the front of the neck, above the windpipe, and does two jobs that have nothing to do with each other. It produces the voice, using the vocal cords — two folds of tissue that vibrate as air passes between them. And it protects the airway, closing when you swallow so that food and drink go down the food pipe instead of into the lungs. A cancer here therefore interferes with two things a patient notices immediately and personally: how they sound, and how safely they can eat.
Almost all laryngeal cancers are squamous cell carcinomas — cancers of the flat cells that line the surface. They arise from that lining, and they grow locally first: into the cords, into the tissue beside them, into the cartilage of the larynx, and outwards into the structures of the neck. Spread to lymph nodes happens earlier in some regions than in others, and spread to distant organs — most often the lungs — is uncommon at diagnosis and is looked for deliberately before a plan is fixed.
The voice is an early alarm in one region and no alarm at all in another. A tumour on the vocal cords makes the voice rough almost as soon as it appears, which is why cancers of the glottis tend to be found while they are still small and confined. A tumour above the cords — in the supraglottis — leaves the voice alone at first, and the neck lymph nodes are usually where it is noticed. That difference, rather than any difference in how aggressive the cancer is, explains why the two present so differently and why they are staged and treated on separate footing.
Nothing about this is self-inflicted in a way that should delay care. Tobacco and alcohol are the dominant causes, and the risk rises with both, but the disease behaves the same way regardless of history, and the treatment options depend on the tumour rather than on the cause. The examination that settles it — a laryngoscopy with a biopsy — is straightforward, and the sooner it happens, the more of the larynx is usually still available to keep.
The three regions of the larynx, and what each one does
The larynx is described in three regions, and a patient will be told which one their tumour is in, because it determines the symptoms, the staging and the operation:
| Region | What it contains | How a tumour here behaves |
|---|---|---|
| Glottis | The vocal cords themselves and the narrow space between them | Changes the voice early, drains into lymph nodes only rarely, and is therefore most often found at an early stage |
| Supraglottis | The tissue above the cords — the epiglottis, the false cords and the space around them | Leaves the voice alone at first, drains freely into the neck nodes, and is often found because of a lump in the neck |
| Subglottis | The tissue below the cords, down to the upper edge of the windpipe | Uncommon, produces a voice change late and can narrow the airway, so it is often found further on |
| Across regions | A tumour large enough to involve more than one region | Described by the region it started in, with the extent recorded — this is what decides whether part or all of the larynx has to go |
Almost all of these tumours are squamous cell carcinomas. Other types exist and are far less common — adenocarcinoma, and the sarcomas and lymphomas that can involve the larynx — and they are treated differently, which is one reason the diagnosis rests on a tissue sample rather than on the appearance of the tumour alone. The distinction between the regions is not academic: it decides which symptoms the patient was likely to notice, where the cancer is looked for next, and whether a partial operation is even anatomically possible.
Stage: how far the tumour reaches and how the cords move
Laryngeal cancer is staged with the TNM system, which describes three separate things: the tumour itself, the neck lymph nodes, and any spread beyond. The stage is a summary, not a grade, and it changes when the vocal cord stops moving — a cord that is fixed means the tumour has reached deeper than its size alone would suggest. The T categories below are the backbone of every treatment decision:
| T category | In plain terms | What it means for the plan |
|---|---|---|
| T1 | The tumour is confined to one region — for example one vocal cord, which still moves normally | A single treatment, either an operation through the mouth or radiotherapy, aims to remove the cancer and keep the larynx |
| T2 | The tumour has reached an adjacent area, or the cord no longer moves normally | Still treated on its own, but the choice between surgery and radiotherapy is weighed more carefully against voice and swallow |
| T3 | The cord is fixed, or the tumour has reached the deep tissue beside the larynx or the inner surface of the cartilage | The two routes are compared directly: surgery with post-operative radiotherapy, or chemoradiotherapy with the larynx kept |
| T4 | The tumour has passed through the cartilage or spread outside the larynx into the neck or the base of the tongue | Removal of the whole larynx is usually the safer route, and the discussion turns on function and on the patient's priorities |
| N | Whether neck lymph nodes are involved, and how many — recorded separately from the tumour | Nodes on both sides, or nodes that have grown beyond their capsule, change the treatment of the neck |
| M | Whether the cancer has spread to a distant organ, most often the lungs | Distant spread makes the aim control of the disease rather than removal of the larynx, and it is looked for before treatment begins |
The practical consequence is that the stage decides the shape of the treatment, not its intensity alone. An early glottic tumour that has not reached the cartilage is managed with one treatment and a plan for surveillance; a tumour that has fixed the cord or crossed into the cartilage has to be considered for both routes and against each other, because the difference between them is what the patient lives with afterwards — a voice and a natural airway, or a stoma and a reconstructed voice. That comparison belongs to a multidisciplinary meeting, with the patient in the conversation.
Tobacco, alcohol and what the tissue test adds
There is no inherited syndrome or single gene that drives laryngeal cancer the way some markers drive other cancers, and treatment is not selected by a genetic test in the ordinary case. What the pathology report does establish is the type of the tumour, how the cells are arranged, whether the margins of an operation are clear, and — where systemic treatment might be used — whether the tumour expresses PD-L1. Two points are worth correcting at the outset, because both are widely misunderstood:
| Point | What is established | What it means in practice |
|---|---|---|
| Tobacco | The dominant cause, with risk rising with years smoked and amount smoked | Stopping remains worthwhile at any point, including after treatment, because it reduces the risk of a second tumour |
| Alcohol | Acts together with tobacco, so the two combined carry a greater risk than either alone | Reducing alcohol is part of the same conversation as stopping smoking, not a separate one |
| HPV | Established as a driver in the oropharynx, but not established in the larynx in the same way | It is tested where the site suggests it, but it is not used here to select treatment or to predict behaviour |
| PD-L1 | Expressed in a proportion of these tumours and used where systemic therapy is considered | Tested on the tissue that is already there — no additional procedure is needed to ask the question |
| Margins and nodes | Reported after any operation, and the main reason radiotherapy is added afterwards | These findings, not the genetic make-up, decide whether post-operative treatment is recommended |
Two conclusions follow. First, for most patients the pathology report answers the questions that matter without any further testing. Second, the report should be read as a whole, because a clear margin on an early tumour and a close margin on a tumour that has reached the cartilage mean very different things for what comes next. If you have a pathology report in hand, it is reasonable to ask directly which of its findings change the plan.
Why patients come to China for laryngeal cancer care
The treatment of laryngeal cancer is decided by a small number of capabilities that have to work together — and it is the combination, not any single one, that the care consists of:
- Organ-preserving surgery through the mouth — transoral laser microsurgery, which removes an early tumour without an incision in the neck and with a planned margin, since the aim is to clear the cancer and leave a voice.
- Radiotherapy as a genuine alternative to surgery — planned and delivered to a defined volume, offered as the whole treatment for early tumours and as part of the organ-preservation route in advanced ones.
- Open surgery where it is needed, and the skill to say when — partial laryngectomy for selected tumours, and total laryngectomy when the extent or the function of the larynx makes preservation unsafe.
- A multidisciplinary meeting before treatment, not after — head and neck surgery, radiation oncology, medical oncology, radiology, pathology, speech and language therapy and nutrition, meeting on the images and the pathology together.
- Voice rehabilitation built into the plan — a tracheoesophageal speech valve, oesophageal speech or an electrolarynx after total laryngectomy, and speech therapy with a defined schedule rather than a referral after the fact.
- Swallowing and nutrition managed throughout — assessment before treatment, support during radiotherapy, and rehabilitation afterwards, since a safe swallow is as much a part of the outcome as the tumour response.
- A stoma and airway team that follows patients for life — care of the tracheal stoma, humidification, and instructions for what to do when something goes wrong at home.
- One written plan, reviewed together — with the route, the rehabilitation and the follow-up schedule set out before treatment starts.
Because this is a cancer in which the choice of treatment is a choice about how life will be lived afterwards, patients who live elsewhere commonly come for the assessment and the first treatment, then return home with a written schedule for voice and swallow rehabilitation and for follow-up. The records that make that workable are the endoscopy images and the biopsy report, the pathology report in full with its margins, the imaging with its reports and dates, the operative and radiotherapy records if treatment has already been given, and the current medication list. Send those, and the written assessment is returned within 48 hours of the file being complete.